Ectoine

DB19171InvestigationalSmall molecule

Ectoine is under investigation in clinical trial NCT03186755 (Clinical Evaluation of Hylo-dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis).

Formula / weight: C₆H₁₀N₂O₂ · 142.158 g/mol (avg)
Also known as: (4s)-3,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid · Ectoin
Code names: NSC-614616

Resolves to

Compound

UNII7GXZ3858RYCAS96702-03-3ChEMBLCHEMBL1230264ChEBI58515KEGGC06231

Clinical / RWD

RxNorm1426644

Structure

InChIKeyWQXNXVUDBPYKBA-YFKPBYRVSA-NSMILESCC1=NCC[C@H](N1)C(O)=O

Transporters

P0AFM2proX

What you can answer from here — as of July 16, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Ectoine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account